Clinical Trial Update: Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions

View source ↗

Summary

A retrospective data collection evaluating routine use of the Spectra Optia device for platelet depletions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myeloproliferative Neoplasm
• Thrombocytosis

Snippet

Sponsor: Terumo BCT | Conditions: Thrombocythemia, Myeloproliferative Disease | Status: COMPLETED | Results posted: 2016-06-15